Scar Treatment Market To Witness An Exuberance At The Rate Of 3% From 2029
Like all the other verticals, the healthcare vertical is poised to witness an amalgamation of collaborations and networks as a result of the culture of belonging and inclusion being the new DNA therein. Also, remote work arrangements will be simplified with shared services, cloud technologies, and AI is in place. The Global Scar Treatment Market is meant to capture these happenings and give insights regarding the same.
According to the
latest market report published by Persistence Market Research, titled “Global Scar Treatment Market is Expected to Reach US$ 12,607.1 Mn
by 2024, Driven by Increasing Awareness and Adoption of Combination Therapies“,
revenue from the global scar treatment market is expected to expand
at a CAGR of 3.8% during the forecast period 2016 – 2024.
In the report, the
global scar treatment market is analyzed based on product type, scar type,
end-user (distribution channel), and region. Based on product type, the overall
market has been segmented into topical products, laser products, surface
treatment products, and injectable products. The topical product segment is
further segmented into creams, gels, oils, and silicone gel sheets. The laser
segment has been sub-segmented into CO2, excimer, and pulse-dyed lasers. Based
on scar type, the market has been sub-segmented into atrophic scars,
hypertrophic scars and keloids, contractures, and stretch marks.
Get
Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/10819
The distribution
channels or end-users in the market include hospitals, private clinics,
pharmacies and retail drug stores, and e-commerce. The market has been analyzed
in terms of value. In the overall market, topical products and atrophic scars
are the prime segments driving revenue growth currently. Accordingly, the
topical product type segment is expected to reach a value of 7,318.7 Mn by the
end of 2024, registering a moderate CAGR over the forecast period.
The prime drivers
for the market include the availability of attractive reimbursement facilities
in developed markets and rising incidences of atrophic scars (primarily acne)
in developing markets, primarily due to rapidly changing food habits and
lifestyles. Furthermore, growing adoption of combination therapeutics is
another factor expected to drive demand for various combinations of scar
treatment product and treatments over the forecast period. Currently, there are
no formalized guidelines for treatment of scars. All treatments are done on a
best-effort basis, guided mostly through word-of-mouth by expert clinicians and
surgeons.
However, efforts
are underway to formalize treatment guidelines at least for common scars. In
this regard, under the U.K. government’s cosmetic intervention guidelines, patient
and patient parties need access to independent and evidence-based information
to form their decisions. Many of these scar treatment and aesthetic
beautification procedures are considered similar to ‘consumer goods’ by both
the purchaser and provider. A change in this perspective could help boost
manufacturers and service provider’s potential revenue base.
Barriers to the
market include fragmented documented clinical evidence for popular topical
products such as onion extract gels (containing silicone). This hampers the
product uptake by the educated section of the patient base in both developed
and developing countries. Other barriers include psychological issues such as
fear of side-effects and consideration of scar treatment as a non-necessary
expenditure item in the overall consumption basket. Even some of the well-known
regulatory agencies do not accept scar treatments as medically necessary as
they mostly aren’t life-changing in nature.
Request
for Methodology@ https://www.persistencemarketresearch.com/methodology/10819
Based on region,
the market has been divided into North America, Latin America, Europe,
Asia-Pacific, and the MEA. Developed pharmaceutical markets such as the U.S.
and EU are expected to emerge as the main markets for scar treatment products
over the forecast period while markets in Brazil and Central Asia are expected
to witness growing adoption of laser treatments due to booming medical tourism
and aesthetic corrective procedures in these regions.
Increasing
involvement of patients in treatment formulation processes is an important
attribute being adopted by reputed physicians as it could lead to a marked
improvement in adherence levels of prescribed treatments and increase treatment
effectiveness.
This report
assesses the market trends, by product, scar type, end-user and region, to
offer analytical insights about the potential emerging demand for particular
scar treatments in specific regions. North America is estimated to dominate the
scar treatment market over the forecast period, accounting for a maximum
revenue share of the overall market by the end of 2015. By 2024 end, North
America and Europe markets are expected to account for over three-fifth market
value share of the global scar treatment market. Markets in Latin America and
APAC region are estimated to expand at the most moderate CAGR over the forecast
period.
Key companies
covered in this report include Smith & Nephew PLC, Merz Inc., Enaltus LLC, Occulus
Innovative Sciences Inc., CCA Industries Inc., Cynosure Inc, Avita Medical
Limited, Lumenis, Syneron Medical Ltd., Nutramarks Inc., Mölnlycke Health Care,
Pacific World Corporation, Valeant Pharmaceuticals International Inc., Shanghai
Fosun Pharmaceuticals Ltd. (AC. Alma Lasers), and Beijing Toplaser Technology
Company Limited. These companies are primarily focused on enhancing their
product portfolio through research and development and on the introduction of
innovative and cost-effective advanced manufacturing procedures in order to
gain higher market share and to strengthen their respective positions in the
global market.
Access
Full Report@ https://www.persistencemarketresearch.com/checkout/10819
About
Us:
Persistence Market
Research is here to provide companies a one-stop solution with regards to
bettering customer experience. It does engage in gathering appropriate feedback
after getting through personalized customer interactions for adding value to
customers’ experience by acting as the “missing” link between “customer
relationships” and “business outcomes’. The best possible returns are assured
therein.
Contact
Us:
Persistence
Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website –
https://www.persistencemarketresearch.com
Comments
Post a Comment